238 related articles for article (PubMed ID: 22100505)
1. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems.
Go YM; Roede JR; Walker DI; Duong DM; Seyfried NT; Orr M; Liang Y; Pennell KD; Jones DP
Mol Cell Proteomics; 2013 Nov; 12(11):3285-96. PubMed ID: 23946468
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Andringa KK; Coleman MC; Aykin-Burns N; Hitchler MJ; Walsh SA; Domann FE; Spitz DR
Cancer Res; 2006 Feb; 66(3):1605-10. PubMed ID: 16452219
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
[TBL] [Abstract][Full Text] [Related]
8. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
9. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
Habermann KJ; Grünewald L; van Wijk S; Fulda S
Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
[TBL] [Abstract][Full Text] [Related]
10. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
11. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.
Hadzic T; Aykin-Burns N; Zhu Y; Coleman MC; Leick K; Jacobson GM; Spitz DR
Free Radic Biol Med; 2010 Apr; 48(8):1024-33. PubMed ID: 20083194
[TBL] [Abstract][Full Text] [Related]
13. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.
Simons AL; Ahmad IM; Mattson DM; Dornfeld KJ; Spitz DR
Cancer Res; 2007 Apr; 67(7):3364-70. PubMed ID: 17409446
[TBL] [Abstract][Full Text] [Related]
14. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia.
Floen MJ; Forred BJ; Bloom EJ; Vitiello PF
Free Radic Biol Med; 2014 Oct; 75():167-77. PubMed ID: 25106706
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
[TBL] [Abstract][Full Text] [Related]
17. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H
Sciegienka SJ; Solst SR; Falls KC; Schoenfeld JD; Klinger AR; Ross NL; Rodman SN; Spitz DR; Fath MA
Free Radic Biol Med; 2017 Jul; 108():354-361. PubMed ID: 28389407
[TBL] [Abstract][Full Text] [Related]
18. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
19. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
[TBL] [Abstract][Full Text] [Related]
20. NO-induced oxidative stress and glutathione metabolism in rodent and human cells.
Luperchio S; Tamir S; Tannenbaum SR
Free Radic Biol Med; 1996; 21(4):513-9. PubMed ID: 8886802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]